The email sent will contain a link to this article, the article title, and an article excerpt (if available). For security reasons, your IP address will also be included in the sent email.
By Viji Sundaram and Zeina Awad, New America Media
Posted on August 7, 2011, Printed on August 8, 2011
http://www.alternet.org/story/151934/big_pharma_testing_drugs_on_india%E2%80%99s_poor
U.S. pharmaceutical companies have moved their operations overseas in the past decade, testing their drugs on poor people in such lands as Russia, China, Brazil and Romania. It is a $30 billion business, and today around 105 countries are allowing such large corporations as Merck and AstraZeneca to conduct clinical trials on their soil.
One country that has experienced a boom like no other in this industry is India, with its widely spoken English, an established medical infrastructure and welcoming attitudes towards foreign industry. Most importantly, these pharmaceutical companies are exploiting the country’s vast number of illiterate and poor people who are willing to become guinea pigs.
Zeina Awad, a reporter for Al Jazeera’s “Fault Lines” program, traveled to India to investigate clinical research being conducted there. She explored what role the United States regulatory agencies are playing in overseeing the clinical trials, and whether the testing complies with international ethical standards.
Her report, “Outsourced: Clinical Trials Overseas,” aired on Al Jazeera English recently.
New America Media Health Editor Viji Sundaram interviewed Awad about what she found.
Return to Article